Rating Change
Ascendiant Capital reiterated its Buy rating on AIM ImmunoTech Inc. (AMEX:AIM) on August 20, 2026.
reiterateAMEX:AIM
Ascendiant Capital Reiterates Buy Rating on AIM ImmunoTech Inc. (AIM)
Ascendiant Capital reiterated its Buy rating on AIM ImmunoTech Inc. (AMEX:AIM) on August 20, 2026.
At publication ·
What changed
AIM ImmunoTech Inc. (AMEX:AIM) · reiterate
- Firm
- Ascendiant Capital
- Rating
- Buy to Buy
- Price at event
- $0.25
- Market capitalization
- $3.1M
At a glance
Key takeaways
- AIM ImmunoTech Inc. trades at $0.25 with a market capitalization of $3.1 million and has declined 89.9% over the past 52 weeks.
Market Context
AIM ImmunoTech Inc. operates in the Healthcare sector. The stock currently trades at $0.25 with a market capitalization of $3.1M. The stock has declined 89.9% over the past 52 weeks.
Analyst coverage from Ascendiant Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for AIM ImmunoTech Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for AIM ImmunoTech Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 20, 2026 | Ascendiant Capital | Buy | N/A |
| Jun 01, 2026 | Ascendiant Capital | Buy | N/A |
| Apr 10, 2026 | Ascendiant Capital | Buy | N/A |
| Dec 08, 2025 | Ascendiant Capital | Buy | N/A |
| Oct 03, 2025 | Ascendiant Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View AIM Stock Page
Frequently Asked Questions
What does the Buy rating mean for AIM?
A rating of Buy from Ascendiant Capital reflects the analyst's outlook on AIM ImmunoTech Inc. (AMEX:AIM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AIM forecast page.